Given the flexibility and breadth of gastric cancer EPO-GEMMs, these models may have a profound impact on gastric cancer research, analogous to the impact of the ‘KPC’ mouse on pancreatic cancer research60, and also enabling the study of a broad range of disease subtypes in reduced time and with less animal waste. This evidence concerns the gene EPO and familial pancreatic carcinoma.